Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Clariane - Rumor of Disposal of the HAD Activity in France

Published 04/04/2024, 18:26

PARIS--(BUSINESS WIRE)--Regulatory News:

Clariane (CLARIA.PA - ISIN FR0010386334): in response to rumours reported in the press, the Company confirms that it is currently studying various targeted disposal options as part of the implementation of its refinancing plan, as announced on 14 November 2023, aimed at improving cash flow generation and controlling debt levels.

In this context, the company confirms that it has held an information meeting with the members of the CSEC, following current French regulations, on the possible sale of its Hospitalisation à Domicile and Services de Soins Infirmiers à Domicile (HAD/SSIAD) business in France.
The Group currently owns 8 specialised HAD homes and 3 SSIAD agencies in France, employing 309 people (full-time equivalent). In 2023, this business generated sales of just over €46 million.
As of the date of this press release, the Group has not received any firm offer to acquire this business.
In this context, the Company will make no further comment on this eventuality and will communicate in due course any element relating to its refinancing plan, in strict compliance with the regulations in force.

About Clariane

Clariane is the leading European community for care in times of vulnerability. It has operations in seven countries: Belgium, France, Germany, Italy, the Netherlands and Spain.

Relying on their diverse expertise, each year the Group's 70,000 professionals provide services to over 900,000 patients and residents in three main areas of activity: long-term care nursing home (Korian, Seniors Residencias,etc.), healthcare facilities and services (Inicea, Ita, Grupo 5, Lebenswert, etc.), and alternative living solutions (Petits-fils, Les essentiels, Ages&Vie, etc.).

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

In June 2023, Clariane became a purpose-driven company and added to its bylaws a new corporate purpose, common to all its activities: To take care of each person's humanity in times of vulnerability.

Clariane has been listed on Euronext Paris Section A since November 2006

Euronext ticker: CLARI - ISIN: FR0010386334

Investor relations

Stéphane Bisseuil
Head of Investor Relations
+33 6 58 60 68 69
stephane.bisseuil@clariane.com

Press

Matthieu Desplats
Press relations Director
+33 6 58 09 01 61
Matthieu.desplats@clariane.com

Julie Mary
Press relations Manager
+33 6 59 72 50 69
julie.mary@clariane.com

Florian Bachelet
Press relations Manager
+33 6 79 86 78 23
florian.bachelet@clariane.com

Source: Clariane

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.